Global Analysis of Protein N-Myristoylation and Exploration of N-Myristoyltransferase as a Drug Target in the Neglected Human Pathogen Leishmania donovani

被引:67
|
作者
Wright, Megan H. [1 ]
Paape, Daniel [2 ]
Storck, Elisabeth M. [1 ]
Serwa, Remigiusz A. [1 ]
Smith, Deborah F. [2 ]
Tate, Edward W. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England
[2] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England
来源
CHEMISTRY & BIOLOGY | 2015年 / 22卷 / 03期
基金
英国生物技术与生命科学研究理事会; 英国惠康基金; 英国医学研究理事会; 英国工程与自然科学研究理事会;
关键词
SMALL-MOLECULE INHIBITORS; ACYLATION; MEMBRANE; DIFFERENTIATION; PROMASTIGOTES; TRAFFICKING; AMASTIGOTES; MALARIA; BINDING; FAMILY;
D O I
10.1016/j.chembiol.2015.01.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
N-Myristoyltransferase (NMT) modulates protein function through the attachment of the lipid myristate to the N terminus of target proteins, and is a promising drug target in eukaryotic parasites such as Leishmania donovani. Only a small number of NMT substrates have been characterized in Leishmania, and a global picture of N-myristoylation is lacking. Here, we use metabolic tagging with an alkyne-functionalized myristic acid mimetic in live parasites followed by downstream click chemistry and analysis to identify lipidated proteins in both the promastigote (extracellular) and amastigote (intracellular) life stages. Quantitative chemical proteomics is used to profile target engagement by NMT inhibitors, and to define the complement of N-myristoylated proteins. Our results provide new insight into the multiple pathways modulated by NMT and the pleiotropic effects of NMT inhibition. This work constitutes the first global experimental analysis of protein lipidation in Leishmania, and reveals the extent of NMT-related biology yet to be explored for this neglected human pathogen.
引用
收藏
页码:342 / 354
页数:13
相关论文
共 50 条
  • [1] Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
    Corpas-Lopez, Victoriano
    Moniz, Sonia
    Thomas, Michael
    Wall, Richard J.
    Torrie, Leah S.
    Zander-Dinse, Dorothea
    Tinti, Michele
    Brand, Stephen
    Stojanovski, Laste
    Manthri, Sujatha
    Hallyburton, Irene
    Zuccotto, Fabio
    Wyatt, Paul G.
    De Rycker, Manu
    Horn, David
    Ferguson, Michael A. J.
    Clos, Joachim
    Read, Kevin D.
    Fairlamb, Alan H.
    Gilbert, Ian H.
    Wyllie, Susan
    ACS INFECTIOUS DISEASES, 2019, 5 (01): : 111 - 122
  • [2] N-Myristoylation as a Drug Target in Malaria: Exploring the Role of N-Myristoyltransferase Substrates in the Inhibitor Mode of Action
    Schlott, Anja C.
    Holder, Anthony A.
    Tate, Edward W.
    ACS INFECTIOUS DISEASES, 2018, 4 (04): : 449 - 457
  • [3] N-Myristoyltransferase from Leishmania donovani: Structural and Functional Characterisation of a Potential Drug Target for Visceral Leishmaniasis
    Brannigan, James A.
    Smith, Barbara A.
    Yu, Zhiyong
    Brzozowski, Andrzej M.
    Hodgkinson, Michael R.
    Maroof, Asher
    Price, Helen P.
    Meier, Franziska
    Leatherbarrow, Robin J.
    Tate, Edward W.
    Smith, Deborah F.
    Wilkinson, Anthony J.
    JOURNAL OF MOLECULAR BIOLOGY, 2010, 396 (04) : 985 - 999
  • [4] Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase
    Rackham, Mark D.
    Yu, Zhiyong
    Brannigan, James A.
    Heal, William P.
    Paape, Daniel
    Barker, K. Victoria
    Wilkinson, Anthony J.
    Smith, Deborah F.
    Leatherbarrow, Robin J.
    Tate, Edward W.
    MEDCHEMCOMM, 2015, 6 (10) : 1761 - 1766
  • [5] PROTEIN N-MYRISTOYLATION AS A CHEMOTHERAPEUTIC TARGET FOR CANCER
    FELSTED, RL
    GLOVER, CJ
    HARTMAN, K
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (21) : 1571 - 1573
  • [6] Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases
    Nascimento, Igor Jose dos Santos
    Cavalcanti, Misael de Azevedo Teotonio
    de Moura, Ricardo Olimpio
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 258
  • [7] N-Myristoylation of Arf proteins in Candida albicans: An in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: Protein N-myristoyltransferase
    Lodge, JK
    JacksonMachelski, E
    Devadas, B
    Zupec, ME
    Getman, DP
    Kishore, N
    Freeman, SK
    McWherter, CA
    Sikorski, JA
    Gordon, JI
    MICROBIOLOGY-UK, 1997, 143 : 357 - 366
  • [8] N-myristoyltransferase:: a prospective drug target for protozoan parasites
    Bowyer, Paul W.
    Tate, Edward W.
    Leatherbarrow, Robin J.
    Holder, Anthony A.
    Smith, Deborah F.
    Brown, Katherine A.
    CHEMMEDCHEM, 2008, 3 (03) : 402 - 408
  • [9] N-MYRISTOYLATION OF P60SRC - IDENTIFICATION OF A MYRISTOYL-COA - GLYCYLPEPTIDE N-MYRISTOYLTRANSFERASE IN RAT-TISSUES
    GLOVER, CJ
    GODDARD, C
    FELSTED, RL
    BIOCHEMICAL JOURNAL, 1988, 250 (02) : 485 - 491
  • [10] Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis
    Ducker, CE
    Upson, JJ
    French, KJ
    Smith, CD
    MOLECULAR CANCER RESEARCH, 2005, 3 (08) : 463 - 476